11/12
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
Low
Report
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
11/5
11:19 am
knsa
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target raised by analysts at JPMorgan Chase & Co. from $39.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target raised by analysts at JPMorgan Chase & Co. from $39.00 to $40.00. They now have an "overweight" rating on the stock.
10/30
11:28 am
knsa
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target raised by analysts at Evercore ISI from $30.00 to $35.00. They now have an "outperform" rating on the stock.
Low
Report
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target raised by analysts at Evercore ISI from $30.00 to $35.00. They now have an "outperform" rating on the stock.
10/29
07:30 am
knsa
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
High
Report
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
10/28
10:45 am
knsa
Here's What Could Help Kiniksa Pharmaceuticals (KNSA) Maintain Its Recent Price Strength [Yahoo! Finance]
Low
Report
Here's What Could Help Kiniksa Pharmaceuticals (KNSA) Maintain Its Recent Price Strength [Yahoo! Finance]
10/28
08:00 am
knsa
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
Low
Report
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
10/22
04:01 pm
knsa
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
Low
Report
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
10/11
10:40 am
knsa
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing' [Yahoo! Finance]
Low
Report
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing' [Yahoo! Finance]
10/9
11:49 am
knsa
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet [Yahoo! Finance]
10/7
01:23 pm
knsa
Kiniksa Pharmaceuticals: Looking In On A Developing Growth Story [Seeking Alpha]
Low
Report
Kiniksa Pharmaceuticals: Looking In On A Developing Growth Story [Seeking Alpha]
10/4
03:33 pm
knsa
New York Rangers Legend Henrik Lundqvist Signs On For ‘Life DisRPted' Campaign [Forbes]
Low
Report
New York Rangers Legend Henrik Lundqvist Signs On For ‘Life DisRPted' Campaign [Forbes]
10/3
06:32 am
knsa
Hockey Hall of Famer spreading awareness on heart condition that forced him into early retirement [FOX News]
Low
Report
Hockey Hall of Famer spreading awareness on heart condition that forced him into early retirement [FOX News]
10/2
12:33 pm
knsa
US Rheumatologists Identify BAFF-R Inhibitors as the Most Promising Treatment Approach for Sjögren's Disease, According to Spherix Global Insights [Yahoo! Finance]
Low
Report
US Rheumatologists Identify BAFF-R Inhibitors as the Most Promising Treatment Approach for Sjögren's Disease, According to Spherix Global Insights [Yahoo! Finance]
10/1
08:00 am
knsa
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
Low
Report
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
9/20
10:29 am
knsa
Kiniksa Pharmaceuticals (KNSA) is on the Move, Here's Why the Trend Could be Sustainable [Yahoo! Finance]
Low
Report
Kiniksa Pharmaceuticals (KNSA) is on the Move, Here's Why the Trend Could be Sustainable [Yahoo! Finance]
9/13
07:59 am
knsa
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $40.00 price target on the stock.
Low
Report
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $40.00 price target on the stock.
8/28
04:01 pm
knsa
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
Low
Report
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference